Halt Aging in Survivors of Blood Cancers

Abroad (travel likely)Recruiting

Conditions

Hematological Malignancy · Leukemia · Lymphoid Leukemia · Multiple Myeloma · Myeloid Leukemia · Monocytic Leukemia · Non-hodgkin Lymphoma · Other Hematologic Condition

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (IIT Office IIT Office) · IITOffice@unmc.edu · 402-559-4596
Contact: Principal Investigator (Vijaya Bhatt, MBBS)

Study leads

Vijaya Raj Bhatt, MBBS,MS
Principal Investigator
University of Nebraska

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Hematologic Malignancy · Blood Cancer · Lymphoma

Abroad (travel likely)Recruiting

Boston, United States

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Lymphoma · Leukemia

Abroad (travel likely)Recruiting

Los Angeles, United States · Bethesda, United States

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes · Chronic Myeloid Leukemia in Remission

Abroad (travel likely)RecruitingPHASE2

Antwerp, Belgium · Bruges, Belgium